#Lundbeck #migraine #Vyepti #clinicaltriadata #EAN2026 #migraineprevention #phase2b #PROCEED #patientcentredoutcomes #chronicmigraine #PACAPpathwayinhibition #phase3 #SUNRISEtrial #phase4 #RESOLUTIONtrial #medicationoveruseheadache #anxiety #depression #headachedays #brainhealth
zurl.co/QrkSV
zurl.co/QrkSV
Lundbeck to present new Vyepti and bocunebart data at EAN 2026 - PharmaTimes
Lundbeck will present new migraine data at the European Academy of Neurology Congress 2026, taking place from 27–30 June in Geneva.
pharmatimes.com
June 29, 2026 at 8:48 AM